Skip to main content
. 2021 Oct 3;8(10):126. doi: 10.3390/jcdd8100126
AF atrial fibrillation
ARBs angiotensin receptor blockers
ASA aspirin
BMS bare metal stent
BNP brain natriuretic peptide
CA coronary angiography
CABG coronary artery bypass grafting
CAD coronary artery disease
CCTA coronary computed tomographic angiography
CMRI cardiac magnetic resonance imaging
COVID-19 2019 Coronavirus disease
ClCr creatinine clearance
CT computed tomography
DAPT dual antiplatelet therapy
DES drug eluting stent
ECG electrocardiogram
FoCUS focused cardiac ultrasound study
GFR glomerular filtration rate
GPIIb-IIIa glycoprotein IIb/IIIa inhibitors
HF heart failure
INR international normalized ratio
LMWH low molecular weight heparin
MACEs major adverse cardiac events
METs metabolic equivalents
MI myocardial infarction
NOACs non-vitamin K antagonist oral anticoagulants
NSQIP National Surgical Quality Improvement Program
NT-proBNP N-terminal-pro hormone BNP
PCI percutaneous coronary intervention
RCRI Revised Cardiac Risk Index
SARS-CoV-2 severe acute respiratory syndrome coronavirus-2
SPECT single-photon emission computed tomography
TTE transthoracic color-Doppler echocardiography
TURP transurethral resection of the prostate
UFH unfractionated heparin
VKAs vitamin K antagonists